Form 4: Femasys CEO Acquires $50K in Convertible Notes, Warrants
Insider Ownership Change
Femasys CEO Kathy Lee-Sepsick acquired $50,000 worth of convertible notes and warrants, signaling a long-term investment in the company.
Summary
- Kathy Lee-Sepsick, the Chief Executive Officer and a Director of Femasys Inc. (FEMY), acquired Senior Secured Convertible Notes and three series of Warrants (A-1, B-1, C-1).
- The total aggregate purchase amount for these derivative securities was $50,000.
- The transaction occurred on November 7, 2025, and was reported on November 19, 2025.
- The Senior Secured Convertible Notes have an initial conversion price of $0.73 per share and expire on November 7, 2035.
- The Series A-1 Warrants have an initial exercise price of $0.81 per share, Series B-1 Warrants at $0.92 per share, and Series C-1 Warrants at $1.10 per share, all expiring on November 7, 2035.
- Each derivative security (Convertible Notes, A-1, B-1, C-1 Warrants) is associated with 68,244 shares of common stock upon conversion or exercise, subject to adjustments and Nasdaq limitations.
- The acquisition was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged transaction.
Sentiment
Score: 7
Explanation: The CEO's direct investment of $50,000 in convertible notes and warrants, especially under a 10b5-1 plan and with long-term maturities, indicates strong management confidence in the company's future. While the amount is not massive, the nature of the investment is positive.
Positives
- CEO Kathy Lee-Sepsick's direct investment of $50,000 in the company's convertible notes and warrants demonstrates strong confidence in Femasys's future prospects.
- The acquisition of long-term derivative securities (expiring in 2035) suggests a long-term commitment from the CEO, aligning her interests with shareholders.
- The transaction was made under a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary purchase, which can be viewed favorably by investors.
Risks
- The conversion and exercise of the derivative securities are subject to certain limitations in accordance with Nasdaq Capital Market rules, which could affect the number of shares ultimately received.
- The value of the underlying common stock could fluctuate, impacting the profitability of converting or exercising the notes and warrants.
Future Outlook
The acquisition of long-term convertible notes and warrants by the CEO suggests an optimistic long-term outlook for Femasys Inc., with potential for significant upside if the stock price appreciates above the conversion/exercise prices.
Management Comments
- The reported securities were purchased by the reporting person for an aggregate amount of $50,000.
Industry Context
Insider purchases, especially by a CEO, are generally seen as a positive signal, indicating management's belief in the company's intrinsic value and future growth prospects. This type of transaction is common in the biotech/medtech industry where Femasys operates, often signaling confidence in upcoming product developments or market expansion.
Comparison to Industry Standards
- Insider buying, particularly by a CEO, is generally viewed as a strong positive signal across all industries, often outperforming general market sentiment.
- The acquisition of derivative securities with long maturities (10 years) is common for long-term strategic investments by insiders, similar to practices seen in companies where executives often hold stock options or convertible debt.
- The specific conversion/exercise prices ($0.73 to $1.10) provide benchmarks for future stock performance relative to the CEO's entry points, which can be compared to similar insider transactions in development-stage companies where executives often invest at various stages of growth.
Stakeholder Impact
- Shareholders: Potential for future dilution if the convertible notes and warrants are converted/exercised, but also a positive signal of management confidence which could boost investor sentiment.
- Creditors: The Senior Secured Convertible Notes represent a debt instrument, which impacts the company's capital structure and obligations to creditors.
Next Steps
- Monitor Femasys Inc.'s stock performance relative to the conversion and exercise prices of the acquired derivatives.
- Observe any future conversions of the notes or exercises of the warrants by Kathy Lee-Sepsick.
- Track Femasys Inc.'s operational and financial results to assess the underlying value supporting the CEO's investment.
Key Dates
| Date | Description |
|---|---|
| 11/07/2025 | Transaction date for the acquisition of Senior Secured Convertible Notes and Series A-1, B-1, and C-1 Warrants. |
| 11/19/2025 | Date the Form 4 was signed and filed. |
| 11/07/2035 | Expiration date for the Senior Secured Convertible Notes and Series A-1, B-1, and C-1 Warrants. |
Recommendation
holdThe CEO's insider purchase is a positive signal, indicating confidence in the company's long-term prospects. However, without additional financial or operational context beyond this Form 4, a 'buy' recommendation would be premature. The investment is relatively small ($50,000) for a CEO, and the transaction, while positive, is a single event. Investors should hold and monitor for further developments and financial performance before making a more aggressive move.
Keywords
Femasys Inc., FEMY, SEC Form 4, Insider Trading, Beneficial Ownership, Convertible Notes, Warrants, CEO Investment, Kathy Lee-Sepsick, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.